Published in Osteoporos Int on May 11, 2011
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Osteoporosis in men: a review. Bone Res (2014) 0.78
Prediction of Mortality and Postoperative Complications using the Hip-Multidimensional Frailty Score in Elderly Patients with Hip Fracture. Sci Rep (2017) 0.77
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study. PLoS One (2015) 0.77
Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood. Z Gerontol Geriatr (2014) 0.77
Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program. BMC Geriatr (2013) 0.75
Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons. Osteoporos Int (2016) 0.75
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) (2005) 4.41
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand (2003) 3.79
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Back to the future: the pyramids of rheumatoid arthritis. J Rheumatol (1997) 2.76
Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum (2006) 2.73
Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int (2001) 2.67
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev (2005) 2.57
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
N of 1 randomized trials for investigating new drugs. Control Clin Trials (1990) 2.37
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Relation between severity of Alzheimer's disease and costs of caring. CMAJ (1998) 2.12
Abnormalities identified in the knees of asymptomatic volunteers using peripheral magnetic resonance imaging. Osteoarthritis Cartilage (2005) 1.98
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract (2012) 1.84
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
The osteoporosis care gap in Canada. BMC Musculoskelet Disord (2004) 1.81
Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum (1993) 1.80
Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J (2008) 1.80
The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int (2012) 1.76
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics (1996) 1.71
Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation (2001) 1.70
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Estimation of creatinine clearance in elderly persons in long-term care facilities. Am J Med (2001) 1.64
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int (2002) 1.61
Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med (1995) 1.61
Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos Int (2000) 1.59
Women's intentions to breastfeed: a population-based cohort study. BJOG (2013) 1.52
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int (2013) 1.46
Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int (2010) 1.46
Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrol Dial Transplant (2005) 1.45
Osteoporosis knowledge and information needs in healthcare professionals caring for patients with fragility fractures. Orthop Nurs (2007) 1.43
Undiagnosed central anticholinergic syndrome may lead to dangerous complications. Eur J Anaesthesiol (1999) 1.42
Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev (2001) 1.42
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
The burden of illness of osteoporosis in Canada. Osteoporos Int (2012) 1.34
Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture. Osteoporos Int (2013) 1.33
Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond) (2008) 1.32
Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int (2008) 1.30
A Canadian physician survey of dyspepsia management. Can J Gastroenterol (1998) 1.30
Antidepressant medications and osteoporosis. Bone (2012) 1.28
Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab (2011) 1.27
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures. Osteoporos Int (2014) 1.22
Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol (1994) 1.20
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19
Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev (2006) 1.19
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int (2001) 1.18
Bone strength: the whole is greater than the sum of its parts. Semin Arthritis Rheum (2006) 1.18
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2003) 1.16
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int (2004) 1.15
Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int (1999) 1.15
Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int (2008) 1.15
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int (2011) 1.13
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol (1994) 1.13
HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet (1987) 1.13
Acupuncture for obesity: a systematic review and meta-analysis. Int J Obes (Lond) (2009) 1.13
Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporos Int (2003) 1.11
Treatment of established bone loss after renal transplantation with etidronate. Transplantation (2001) 1.11
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns (2008) 1.09
Osteoporosis management among residents living in long-term care. Osteoporos Int (2009) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Res Clin Pract (2008) 1.07
The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol Psychiatry (2012) 1.04
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab (1997) 1.04
Gymnastic training and bone density in pre-adolescent females. Med Sci Sports Exerc (1997) 1.04
The Ontario Osteoporosis Strategy: implementation of a population-based osteoporosis action plan in Canada. Osteoporos Int (2010) 1.03
Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int (2003) 1.01
Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. J Am Geriatr Soc (1999) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00
Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database Syst Rev (2000) 0.99
Is peri-operative cortisol secretion related to post-operative cognitive dysfunction? Acta Anaesthesiol Scand (2005) 0.99
Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients. J Rheumatol (1984) 0.99